Comrade Xiao Wei, doctor and researcher of traditional Chinese medicine, doctoral supervisor of Beijing University of Traditional Chinese Medicine, doctoral supervisor of Nanjing University of Traditional Chinese Medicine, distinguished professor of Anhui College of Traditional Chinese Medicine, visiting professor of Qingdao Ocean University, and the first batch of young and middle-aged scientific and technological leaders in Jiangsu Province have won honorary titles such as Jiangsu Model Worker, Jiangsu Excellent Entrepreneurial Entrepreneur, Jiangsu First Top Ten Excellent Patent Inventors, Jiangsu Innovative and Entrepreneurial Talents, and enjoyed special allowances from the State Council. Currently, he is the chairman of Jiangsu Kangyuan Pharmaceutical Co., Ltd., the director of "State Key Laboratory of New Technology in Pharmaceutical Process of Traditional Chinese Medicine", the representative of the 11th National People's Congress, the Standing Committee of Lianyungang Municipal People's Congress, the alternate member of Lianyungang Municipal Committee, the member of the National Pharmacopoeia Committee and the member of the state administration of traditional chinese medicine Traditional Chinese Medicine Standardization Expert and Technical Committee.
Comrade Xiao Wei has been engaged in the research and development of modern Chinese medicine for a long time, and constantly uses the new technology, new dosage forms and new auxiliary materials of modern medicine research to enhance and enrich the technical connotation of traditional Chinese medicine. He led the R&D team to carry out more than 7 new drug researches, and obtained 47 new drug certificates. Apply for 18 invention patents at home and abroad, and obtain 89 domestic invention patents and 1 foreign invention patents; It has undertaken 24 scientific research projects at or above the provincial level, including 13 national key projects such as the Ninth Five-Year Plan, the Tenth Five-Year Plan, the Eleventh Five-Year Plan, the Ministry of Science and Technology's major new drug creation project, and the "973" plan. Accumulated 36 papers and 3 monographs; The research and development project of new Chinese medicine that he presided over won many national and provincial awards, among which Jinzhen Oral Liquid was awarded the second prize of scientific and technological progress in 2 by the State Economic and Trade Commission, and five projects including Guizhi Fuling Capsule, Tianshu Capsule, Reduning Injection and Tongan Injection won the provincial scientific and technological progress prize. Five products, including Yuanhu Zhitong Soft Capsule, were rated as national new products; After years of market cultivation, Guizhi Fuling Capsule, a national new drug developed by Guizhi Fuling Capsule, has developed into the first choice for treating gynecological blood stasis in China. It has passed the FDA IND review in the United States and is in the second phase of clinical research in the United States. In 211, the project "Establishment and Application of Control System of Traditional Chinese Medicine Injection" led by Xiao Wei won the first prize of Jiangsu Science and Technology Progress Award.